OSR Health

Grow Your Shares by Staying Invested as Milestones are Met

OSR Health has launched a Shareholder Loyalty CVR Program designed to reward the investors who hold OSRH stock over the 12 month timeline.

Under the program, the Company plans to offer an equal opportunity to all shareholders of record as of August 14, 2026 to enroll into the program to receive one (1) Contingent Value Right ("CVR") for every share owned. Each CVR provides the opportunity to receive additional common shares if OSRH reaches defined price milestones and the shareholder continues to hold their original shares.

Tier, Holding Period	Price Trigger	CVR Delivery	Cumulative Position
Tier 1, 3 months	≥ $2.00	0.5 new shares per CVR	1.5× original position
Tier 2, 6 months	≥ $3.00	1.0 new shares per CVR	2.5× original position
Tier 3, 9 months	≥ $4.00	1.5 new shares per CVR	4.0× original position
Tier 4, 12 months	≥ $5.00	2.0 new shares per CVR	6.0× original position

- If the defined milestones are achieved during the twelve months following the record date, shareholders who continuously hold their original shares would receive additional shares of common stock — all that is being requested is to hold your shares without selling or lending them until each Measurement Date.
- The price triggers are planned to be measured using the closing price on each of the 3, 6, 9, and 12 month anniversaries of the record date. The rewards are cumulative — a shareholder who holds throughout the period, if all four milestones are achieved, would receive a total of five additional shares for each share originally held, growing their position to six times its original size.
- The CVRs are designed to reward continuous ownership. They will be non-transferable and will automatically terminate and cease to have any value if the original shares are sold, lent, transferred, or otherwise ceases to be continuously beneficially owned by the original shareholder.

How to Qualify for Shareholder Loyalty CVRs

1. Enroll

By Record Date (August 14, 2026) — hold your OSRH shares.
US shareholders must move their shares to Direct Registration System (DRS), by instructing their broker (or custodian) to initiate the DRS transfer as soon as possible and NO LATER THAN Monday, August 17, 2026. See "How to Enroll" for more details.
During the Enrollment Window (August 14 – September 13, 2026) — complete and return the CVR Enrollment Agreement.
Non-US shareholders must submit their initial Broker Attestation (confirming holding as of August 14) during the Enrollment Window. See "How to Enroll" for more details.
US shareholders are verified automatically via DRS.

2. Own

Hold your shares continuously from the Record Date through each Measurement Date. Selling, transferring, or lending cancels the corresponding CVRs.

3. Confirm & Receive

Non-US shareholders re-attest within 15 days after each Measurement Date by submitting an updated Broker Attestation as of Measurement Date.
US shareholders are verified automatically via DRS.
Receive additional shares as each closing-price threshold is met:
- Nov 13, 2026, ≥ $2.00, +0.5 shares
- Feb 12, 2027, ≥ $3.00, +1.0 shares
- May 14, 2027, ≥ $4.00, +1.5 shares
- Aug 13, 2027, ≥ $5.00, +2.0 shares

Share deliveries are subject to regulatory clearance and OSRH's continued Nasdaq listing.

Grow Your Shares by Staying Invested as Milestones are Met

OSR Health has launched a Shareholder Loyalty CVR Program designed to reward the investors who hold OSRH stock over the 12 month timeline.

Under the program, the Company plans to offer an equal opportunity to all shareholders of record as of August 14, 2026 to enroll into the program to receive one (1) Contingent Value Right ("CVR") for every share owned. Each CVR provides the opportunity to receive additional common shares if OSRH reaches defined price milestones and the shareholder continues to hold their original shares.

Tier, Holding Period	Measurement Date	Price Trigger	CVR Delivery	Cumulative Position
Tier 1, 3 months	November 13, 2026	≥ $2.00	0.5 new shares per CVR	1.5× original position
Tier 2, 6 months	February 12, 2027	≥ $3.00	1.0 new shares per CVR	2.5× original position
Tier 3, 9 months	May 14, 2027	≥ $4.00	1.5 new shares per CVR	4.0× original position
Tier 4, 12 months	August 13, 2027	≥ $5.00	2.0 new shares per CVR	6.0× original position

- If the defined milestones are achieved during the twelve months following the record date, shareholders who continuously hold their original shares would receive additional shares of common stock — all that is being requested is to hold your shares without selling or lending them until each Measurement Date.
- The price triggers are planned to be measured using the closing price on each of the 3, 6, 9, and 12 month anniversaries of the record date. The rewards are cumulative — a shareholder who holds throughout the period, if all four milestones are achieved, would receive a total of five additional shares for each share originally held, growing their position to six times its original size.
- The CVRs are designed to reward continuous ownership. They will be non-transferable and will automatically terminate and cease to have any value if the original shares are sold, lent, transferred, or otherwise ceases to be continuously beneficially owned by the original shareholder.

How to Qualify for Shareholder Loyalty CVRs

1. Enroll

By Record Date (August 14, 2026) — hold your OSRH shares.
US shareholders must move their shares to Direct Registration System (DRS), by instructing their broker (or custodian) to initiate the DRS transfer as soon as possible and NO LATER THAN Monday, August 17, 2026. See "How to Enroll" for more details.
During the Enrollment Window (August 14 – September 13, 2026) — complete and return the CVR Enrollment Agreement.
Non-US shareholders must submit their initial Broker Attestation (confirming holding as of August 14) during the Enrollment Window. See "How to Enroll" for more details.
US shareholders are verified automatically via DRS.

2. Own

Hold your shares continuously from the Record Date through each Measurement Date. Selling, transferring, or lending cancels the corresponding CVRs.

3. Confirm & Receive

Non-US shareholders re-attest within 15 days after each Measurement Date by submitting an updated Broker Attestation as of Measurement Date.
US shareholders are verified automatically via DRS.
Receive additional shares as each closing-price threshold is met:
- Nov 13, 2026, ≥ $2.00, +0.5 shares
- Feb 12, 2027, ≥ $3.00, +1.0 shares
- May 14, 2027, ≥ $4.00, +1.5 shares
- Aug 13, 2027, ≥ $5.00, +2.0 shares

Share deliveries are subject to regulatory clearance and OSRH's continued Nasdaq listing.

US Shareholders

If you are a U.S. person whose shares are held through a U.S. broker, taking part requires holding your shares through the Direct Registration System (DRS) and 2) a completed CVR Enrollment Agreement.

What is DRS?

DRS records your OSR Health (NASDAQ: OSRH) shares directly in your own name on the Company’s register, rather than through your broker’s “street name.” You stay the full owner of your shares, there are no paper certificates, and you can buy or sell at any time. It’s a secure, widely used method of direct share ownership.

Why it’s required

Holding in DRS lets the Company confirm your continuous ownership directly, so it can track eligibility and administer the program accurately and fairly. It changes only how your shares are registered—not how many you own or your rights as a shareholder.

What to do

Contact your broker and request a DRS transfer of your OSRH shares to the Company's transfer agent, using these details:
Transfer Agent: Continental Stock Transfer & Trust

Address: 1 State Street, 30th Floor, New York, NY 10004

DTC/Limited Participant Account (LPA) number: 7808
Instruct your broker (or custodian) to initiate the DRS transfer no later than Monday, August 17, 2026. Broker processing takes time—start now.
Complete enrollment by signing the CVR Enrollment Agreement (available from August 14) within the 30 day Enrollment Window.

If your broker does not support DRS: Some brokers—including certain app-based platforms such as Robinhood—do not offer DRS transfers. If yours does not, you will first need to transfer your OSRH shares (via an ACATS transfer) to a broker that does support DRS, and then request the DRS transfer to Continental Stock Transfer & Trust. This two-step process takes additional time, so please allow extra time and begin well in advance. Processing times vary by broker, so start the DRS transfer well before the Record Date.

Important to Understand

DRS shares are not freely tradeable from a standard brokerage account. To sell, you must first re-transfer them to a broker (3–5 business days)
Any re-transfer, sale, or transfer permanently cancels the corresponding CVRs—repurchasing later does not restore them
DRS shares cannot be lent through a securities-lending program.

Non-US Shareholders / 비미국 주주

If you are not a U.S. person, or your shares are held through a non-U.S. broker, you confirm ownership with a Broker Attestation—at enrollment and after each measurement date

Canadian Persons: Canadian persons whose broker supports DRS are encouraged to move their shares to DRS. To do so, please follow the instructions for US shareholders.

What is a broker attestation?

It’s a written confirmation from your broker verifying that you held your OSR Health (NASDAQ: OSRH) shares on the required date. The document must bear the broker-dealer's official seal, wet-ink signature of an authorized officer, or equivalent electronic authentication issued by the institution. The statement may be in any language; no certified translation is required;

Why it’s required

Regular attestations let the Company confirm you have held your shares continuously, so it can track eligibility and administer the program accurately and fairly.

How to submit

Have your broker complete and sign a Broker Attestation form.
Submit it electronically via the Enrollment Portal within 30 days of the record date
Mail the original signed form to the Company's South Korea address: B-dong, 3F, 37-36 Hoedong-gil, Paju-si 10881, Gyeonggi-do, South Korea

Remember: a new attestation is required within 15 days of each measurement date—not just when you enroll. Keep note of the measurement dates so your enrollment stays active.

귀하가 미국인이 아니거나, 귀하의 주식이 비미국 증권사를 통해 보유되고 있는 경우, 등록 시점 및 각 평가일 이후에 증권사 확인서를 통해 소유권을 확인해야 합니다.

캐나다인:이용 중인 증권사가 DRS를 지원하는 캐나다인은 주식을 DRS로 이전할 것을 권장합니다. 이를 위해 미국 주주를 위한 안내에 따라 주시기 바랍니다.

증권사 확인서란 무엇인가요?

증권사 확인서는 귀하가 요구되는 날짜에 OSR Health(NASDAQ: OSRH) 주식을 보유하고 있었음을 증권사가 확인하는 서면 확인서입니다. 해당 문서에는 증권사/브로커딜러의 공식 직인, 권한 있는 임원의 자필 서명, 또는 해당 기관이 발행한 이에 준하는 전자 인증이 포함되어야 합니다. 확인서는 어떤 언어로 작성되어도 무방하며, 공증 번역은 필요하지 않습니다.

왜 필요한가요?

정기적인 확인서를 통해 회사는 귀하가 주식을 계속 보유하고 있었는지 확인할 수 있으며, 이를 바탕으로 자격 여부를 추적하고 프로그램을 정확하고 공정하게 운영할 수 있습니다.

제출 방법

증권사가 증권사 확인서 양식을 작성하고 서명하도록 하십시오.
기준일로부터 30일 이내에 등록 포털을 통해 전자적으로 제출하십시오.
서명된 원본 양식을 회사의 대한민국 주소로 우편 발송하십시오: 대한민국 경기도 파주시 회동길 37-36, 3층 B동, 10881

유의사항:신규 확인서는 등록 시에만 필요한 것이 아니라, 각 평가일로부터 15일 이내에 매번 제출해야 합니다. 등록 상태가 계속 유효하게 유지되도록 평가일을 기록해 두시기 바랍니다.

Important Terms & Risks — Please Read

Continuous Holding is Required

Selling, transferring, or lending your enrolled shares at any time automatically and permanently cancels the corresponding CVRs. CVRs are personal and non-transferable, and carry no voting or dividend rights.

Delivery Timing is Subject to SEC Registration

Distribution of CVRs and delivery of shares are subject to U.S. securities-law requirements. The Company expects the CVRs and related shares to be registered pursuant to a registration statement on Form S-1, or Form S-3 if available. Any distribution or delivery will be subject to the effectiveness of the applicable registration statement. Timing and effectiveness are not guaranteed, and deliveries may be materially deferred. Enrollment does not guarantee a specific delivery date.

Conditioned on Continued Nasdaq Listing

All deliveries depend on OSRH remaining listed on Nasdaq. If OSRH is delisted and not cured within 30 days, remaining measurement dates are cancelled and active CVRs expire without delivery.

Who is Eligible to Participate in the Shareholder Loyalty CVR Program?

All shareholders who own OSR Health common stock as of the applicable Record Date (August 14) are eligible to apply for the Shareholder Loyalty CVR Program. Shareholders must complete the CVR Enrollment Agreement and satisfy all the applicable program requirements before Contingent Value Rights (CVRs) are issued.

How Do I Enroll?

Enrollment is completed by submitting the CVR Enrollment Agreement and meeting the program requirements.

U.S. shareholders will need to hold their shares through Direct Registration (DRS) with the Company's transfer agent before enrolling.

Non-U.S. shareholders need to provide a Broker Attestation at Enrollment and also at each Measurement Date.

Full instructions are made available on this page. The CVR Enrollment Agreement will be made available from August 14.

Do I Need to do Anything After Enrolling?

Once your Enrollment has been approved, no further action is generally required. Simply continue to hold your enrolled shares and remain eligible under the terms of the program.

If applicable share price milestones are achieved during the program period, enrolled US shareholders will receive the corresponding share distributions in accordance with the program terms and their DRS position.

Non-US shareholders will have to provide a subsequent Broker Attestation within 15 days of each Measurement Date to confirm their original shares position.

As a US Shareholder, Can I Enroll via Broker Attestation Rather Than DRS?

No. US and non-US shareholders enroll through different methods, and US shareholders cannot use the Broker Attestation route.

US shareholders must move their shares into the Direct Registration System (DRS) with our transfer agent, Continental Stock Transfer & Trust. The DRS lets the Company verify a US shareholder's continuous ownership directly and in real time on its own register — the most accurate and reliable method. Because U.S. shareholders have access to DRS, they are required to use it. Non-US shareholders instead confirm their holdings through a Broker Attestation.

What Happens if I Sell My Shares?

The Shareholder Loyalty CVR Program is designed to reward long-term ownership. If you sell, transfer, or otherwise dispose of the shares associated with your CVRs before the applicable milestone is achieved, those CVRs will immediately terminate and will no longer be eligible to receive additional shares.

Extra shares recieved by reaching are milestones are free to be sold and don't affect future milestone rewards associated with the CVRs from the original shares held on record date.